UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 716

Sortiert nach

The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer

Endocrine-related cancer, 2015-02, Vol.22 (1), p.R1-R31

Jordan, V Craig

2015

Volltextzugriff (PDF)

50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened?

Endocrine-related cancer, 2021-01, Vol.28 (1), p.R11-R30

Jordan, V Craig

2021

Volltextzugriff (PDF)

Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team

Breast cancer research and treatment, 2021-11, Vol.190 (1), p.19-38

Jordan, V. Craig

2021

Volltextzugriff (PDF)

Tamoxifen: Catalyst for the change to targeted therapy

European journal of cancer (1990), 2008-01, Vol.44 (1), p.30-38

Jordan, V. Craig

2008

Volltextzugriff (PDF)

Tamoxifen Resistance Trumped and Oral Selective Estrogen Receptor Degraders Arrive

Clinical cancer research, 2018-08, Vol.24 (15), p.3480-3482

Jordan, V Craig

2018

Volltextzugriff (PDF)

The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice

Current clinical pharmacology, 2013-05, Vol.8 (2), p.135

2013

Volltextzugriff (PDF)

Selective Estrogen-Receptor Modulators and Antihormonal Resistance in Breast Cancer

Journal of clinical oncology, 2007-12, Vol.25 (36), p.5815-5824

2007

Volltextzugriff (PDF)

A Century of Deciphering the Control Mechanisms of Sex Steroid Action in Breast and Prostate Cancer: The Origins of Targeted Therapy and Chemoprevention

Cancer research (Chicago, Ill.), 2009-02, Vol.69 (4), p.1243-1254

JORDAN, V. Craig

2009

Volltextzugriff (PDF)

Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer

British journal of pharmacology, 2006-01, Vol.147 (S1), p.S269-S276

Jordan, V Craig

2006

Volltextzugriff (PDF)

The 38th David A. Karnofsky Lecture: The Paradoxical Actions of Estrogen in Breast Cancer—Survival or Death?

Journal of clinical oncology, 2008-06, Vol.26 (18), p.3073-3082

JORDAN, V. Craig

2008

Volltextzugriff (PDF)

Tamoxifen Tales: Suggestions for Scientific Survival

Jordan, V. Craig

1, 2022

Volltextzugriff (PDF)

Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents

Journal of medicinal chemistry, 2003-03, Vol.46 (7), p.1081-1111

Jordan, V. Craig

2003

Volltextzugriff (PDF)

DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination

Gynecologic oncology, 2012-10, Vol.127 (1), p.241-248

2012

Volltextzugriff (PDF)

Estrogen Receptor and the Unfolded Protein Response: Double-Edged Swords in Therapy for Estrogen Receptor-Positive Breast Cancer

Targeted oncology, 2022-03, Vol.17 (2), p.111-124

2022

Volltextzugriff (PDF)

Estrogen-Induced Apoptosis in Breast Cancers Is Phenocopied by Blocking Dephosphorylation of Eukaryotic Initiation Factor 2 Alpha (eIF2α) Protein

Molecular cancer research, 2019-04, Vol.17 (4), p.918-928

2019

Volltextzugriff (PDF)

Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics

Genome research, 2012-06, Vol.22 (6), p.1015

2012

Volltextzugriff (PDF)

Telling details of breast-cancer recurrence

Nature (London), 2018-01, Vol.553 (7687), p.155-155

2018

Volltextzugriff (PDF)

Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer

Molecular pharmacology, 2018-08, Vol.94 (2), p.812-822

2018

Volltextzugriff (PDF)

Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer

Endocrine-related cancer, 2014-06, Vol.21 (3), p.R235-R246

Jordan, V Craig

2014

Volltextzugriff (PDF)

Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer

Steroids, 2007-01, Vol.72 (1), p.7-25

2007

Volltextzugriff (PDF)

Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations

Steroids, 2014-11, Vol.90, p.44-52

2014

Volltextzugriff (PDF)

Progress in endocrine approaches to the treatment and prevention of breast cancer

Maturitas, 2011-12, Vol.70 (4), p.315-321

2011

Volltextzugriff (PDF)

Early breast cancer

The Lancet (British edition), 2009-04, Vol.373 (9673), p.1463-1479

2009

Volltextzugriff (PDF)

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

Cancer prevention research (Philadelphia, Pa.), 2010-06, Vol.3 (6), p.696-706

2010

Volltextzugriff (PDF)

International Union of Pharmacology. LXIV. Estrogen receptors

Pharmacological reviews, 2006-12, Vol.58 (4), p.773

2006

Volltextzugriff (PDF)

1 – 25 von 716

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(632)
Mit Volltextzugriff
(602)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(715)
Japanisch
(78)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(442)
Life Sciences & Biomedicine
(423)
Humans
(422)
Female
(369)
Oncology
(247)
Biological And Medical Sciences
(204)
Medical Sciences
(188)
Animals
(179)
Breast Neoplasms - Drug Therapy
(177)
Breast Cancer
(151)
Tamoxifen - Therapeutic Use
(135)
Tamoxifen - Pharmacology
(126)
Pharmacology. Drug Treatments
(120)
Tamoxifen
(104)
Breast Neoplasms - Metabolism
(101)
Breast Neoplasms - Pathology
(94)
Tumors
(91)
Antineoplastic Agents
(90)
Receptors, Estrogen - Metabolism
(82)
Breast Neoplasms - Prevention & Control
(79)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer

50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened?

Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team

Tamoxifen: Catalyst for the change to targeted therapy

Tamoxifen Resistance Trumped and Oral Selective Estrogen Receptor Degraders Arrive

The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice

Selective Estrogen-Receptor Modulators and Antihormonal Resistance in Breast Cancer

A Century of Deciphering the Control Mechanisms of Sex Steroid Action in Breast and Prostate Cancer: The Origins of Targeted Therapy and Chemoprevention

Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer

The 38th David A. Karnofsky Lecture: The Paradoxical Actions of Estrogen in Breast Cancer—Survival or Death?

Tamoxifen Tales: Suggestions for Scientific Survival

Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents

DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination

Estrogen Receptor and the Unfolded Protein Response: Double-Edged Swords in Therapy for Estrogen Receptor-Positive Breast Cancer

Estrogen-Induced Apoptosis in Breast Cancers Is Phenocopied by Blocking Dephosphorylation of Eukaryotic Initiation Factor 2 Alpha (eIF2α) Protein

Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics

Telling details of breast-cancer recurrence

Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer

Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer

Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer

Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations

Progress in endocrine approaches to the treatment and prevention of breast cancer

Early breast cancer

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

International Union of Pharmacology. LXIV. Estrogen receptors

Suchergebnisse filtern